Filing Details
- Accession Number:
- 0001640334-20-002029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-11 15:15:59
- Reporting Period:
- 2020-08-07
- Accepted Time:
- 2020-08-11 15:15:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1516551 | Emerald Bioscience Inc. | EMBI | Pharmaceutical Preparations (2834) | 450692882 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1728413 | Emerald Health Sciences Inc. | Office 8262 The Landing, 200-375 Water St. Vancouver A1 V6B 0M9 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-08-07 | 3,000,000 | $0.10 | 123,490,167 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Transfer of shares in a private transaction to directors, employees and consultants.
Billionaire Hedge Funds
